-
1
Metabolic syndrome (MetS) affects 40-50% of individuals with bipolar disorder (BD), significantly increasing the risk of cardiovascular disease and diabetes.
-
2
The comorbidity of BD and MetS is influenced by behavioral risk factors, inflammatory pathways, and the metabolic effects of psychotropic medications.
-
3
Systematic metabolic monitoring and lifestyle interventions, such as nutrition and physical activity, are essential for managing cardiometabolic risks in individuals with BD.
-
4
Emerging treatments like GLP-1 receptor agonists and ketogenic therapy show promise for metabolic health in BD patients but require careful clinical integration.
-
5
A multidisciplinary approach, involving collaboration between psychiatry and metabolic specialists, is crucial for improving health outcomes in individuals with BD and MetS.
